Table 2. Changes in pain, HRQoL, and fall risk among treatment groups.
| HILT + EX | PL + EX | HILT | PL | |||||
|---|---|---|---|---|---|---|---|---|
| Pre | 12 W | Pre | 12 W | Pre | 12 W | Pre | 12 W | |
| Pain level (VAS)* | 5.6 ± 1.2 | 0.7 ± 0.5** | 5.3 ± 1.0 | 1.8 ± 0.7** | 5.1 ± 1.0 | 1.1 ± 0.7** | 5.2 ± 1.2 | 3.6 ± 0.9** |
| HRQoL* | 47.8 ± 5.2 | 22.5 ± 4.6** | 46.2 ± 4.6 | 28.4 ± 5.5** | 45.3 ± 4.4 | 35.2 ± 5.6** | 44.6 ± 5.3 | 42.4 ± 3.7** |
| Fall risk* | 3.2 ± 0.6 | 2.2 ± 0.5 | 2.9 ± 0.9 | 2.5 ± 0.8 | 3.2 ± 0.8 | 3.1 ± 0.7 | 3.0 ± 0.9 | 2.9 ± 0.9** |
HILT: high intensity laser therapy; EX: exercises; PL: placebo laser; 12 W: 12 weeks, VAS: visual analogue scale, HRQoL: health related quality of life. Data are expressed as mean ± standard deviation. *Significant difference in the post treatment measurement among treatment groups. **Significant difference in each treatment group in post treatment as compared to baseline values.